glp-1 obesity drugs pipeline Top and Diabetes Medications Transforming U.S. Pharma Market In 5 years, obesity drugs
Description
Detailed interpretable trees for endometrial, ovarian, meningioma, and kidney cancers are provided in eFigure 4AD in Supplement 1
95% CI 0.18 to 0.09
doi:10.6061/clinics/2015(11)09
Comparison of the Effects of Liraglutide, Tirzepatide, and Retatrutide on Diabetic Kidney Disease in Db/Db Mice
